Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Nfib in hair follicle stem cells boosts melanocyte stem cell growth and differentiation.

Botulinum toxin type A injections are the preferred treatment for Frey's syndrome after parotid surgery.

Eating phenylthiocarbamide made all the rats' hair go gray, but some returned to their original color after stopping.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Angiogenesis can be controlled by balancing stimulators like VPF/VEGF and inhibitors like TSP.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Hair plucking quickly increases antizyme, reducing a specific enzyme activity in rats.

Lack of FPR2 slows hair growth by affecting hair cell activity.

Hair sheds gradually from the follicle, with readiness to shed indicated by less attachment material.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

PRP can improve hair growth in people with hair loss, but more research is needed.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Dopamine receptors in the brain influence itch-related scratching behavior.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Certain chemical changes to cortisol and progesterone can increase or decrease their ability to inhibit hair growth.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

MOF controls skin development by regulating genes for mitochondria and cilia.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Focal atrichia helps diagnose female pattern hair loss.